Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00478426
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more
National Cancer Institute (NCI) 34
Not applicableLooking for participantsNCT06890273
What this trial is testing

NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

Who this might be right for
Endometrial Cancer
AstraZeneca 150
Testing effectiveness (Phase 2)Looking for participantsNCT03832361
What this trial is testing

Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

Who this might be right for
Endometrial Cancer
Alessandro Santin 50
Large-scale testing (Phase 3)Study completedNCT03603184
What this trial is testing

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Who this might be right for
Endometrial Cancer
Mario Negri Institute for Pharmacological Research 549
Testing effectiveness (Phase 2)Ended earlyNCT05523440
What this trial is testing

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Ovarian CarcinomaARID1A Gene Mutation
University of Oklahoma 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07578649
What this trial is testing

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsEndometrial Cancer
Pfizer 600
Post-approval studies (Phase 4)Not Yet RecruitingNCT07652515
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00258362
What this trial is testing

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)WithdrawnNCT06385548
What this trial is testing

Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer

Who this might be right for
Endometrial Cancer
Vall d'Hebron Institute of Oncology
Early research (Phase 1)Looking for participantsNCT06795009
What this trial is testing

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Who this might be right for
Uterine CancerEndometrial Cancer
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00401635
What this trial is testing

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Who this might be right for
Endometrial Cancer
National Cancer Institute, Naples 42
Large-scale testing (Phase 3)UnknownNCT02584478
What this trial is testing

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Who this might be right for
Endometrial CarcinomaOvarian CarcinomaFallopian Tube Carcinoma+2 more
Advenchen Laboratories, LLC 294
Testing effectiveness (Phase 2)Study completedNCT04205630
What this trial is testing

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Byondis B.V. 64
Testing effectiveness (Phase 2)Ended earlyNCT02059265
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Testing effectiveness (Phase 2)Study completedNCT00659360
What this trial is testing

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00006089
What this trial is testing

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaERBB2 Gene AmplificationRecurrent Uterine Corpus Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)UnknownNCT03951415
What this trial is testing

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

Who this might be right for
Endometrial NeoplasmsUterine NeoplasmsEndometrium Cancer
Leiden University Medical Center 55
Next Page